Amryt Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Amryt Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 214% to $182,607,000. Profit margin reached -57%. Total operating expenses were $109,020,000.
Profit Margin
| 2010 | 0 | -123.57K | |
|---|---|---|---|
| 2011 | 0 | -3.05M | |
| 2012 | 0 | -826.11K | |
| 2015 | 0 | -39.74M | |
| 2016 | 1.42M | -8.20M | -577.65% |
| 2017 | 15.32M | -31.35M | -204.54% |
| 2018 | 16.53M | -29.48M | -178.34% |
| 2019 | 58.12M | -65.53M | -112.75% |
| 2020 | 182.60M | -104.52M | -57.24% |
AMYT.L Income Statement (2010 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 182.60M | 58.12M | 16.53M | 15.32M | 1.42M | 0 | 0 | 0 | 0 |
Cost of revenue | 119.02M | 42.00M | 6.06M | 6.44M | 616.29K | 0 | 0 | 0 | 0 |
Gross profit | 63.57M | 16.12M | 10.47M | 8.88M | 804.55K | 0 | 0 | 0 | 0 |
Operating exp. | |||||||||
Research and development | 27.61M | 15.82M | 10.35M | 12.67M | 2.46M | 0 | 0 | 0 | 0 |
Selling and marketing | 76.67M | 35.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 109.02M | 52.16M | 27.91M | 25.92M | 6.95M | 3.33M | 275.37K | 281.22K | 281.81K |
Operating income | -45.44M | -36.04M | -17.44M | -17.04M | -6.14M | -3.33M | -275.37K | -281.22K | -281.81K |
Other income (expenses), net | -60.41M | -30.71M | -12.00M | -14.31M | -2.06M | -36.40M | 0 | 0 | 0 |
Income before tax | -105.85M | -66.76M | -29.44M | -31.35M | -8.20M | -39.74M | -275.37K | -281.22K | -281.81K |
Income tax expense | -1.33M | -1.22M | 41.18K | -13.29M | -2.05M | -36.40M | 0 | 0 | 1.50K |
Net income | -104.52M | -65.53M | -29.48M | -31.35M | -8.20M | -39.74M | -826.11K | -3.05M | -123.57K |
Earnings per share | |||||||||
Basic EPS | -1.38 | -0.86 | -0.64 | -0.84 | -0.3 | -5.52 | -4.96 | -18.46 | -2.19 |
Diluted EPS | -1.38 | -0.86 | -0.64 | -0.84 | -0.3 | -5.52 | -4.96 | -18.46 | -2.19 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |